Workstream 2

Workstream 2 is evaluating blood and imaging tests that could help to detect UGI cancers earlier. These will include existing tests, as well as new biomarkers and hospital-based imaging tests that could be made accessible to the community. A range of methods will be used, including systematic reviews, biochemical assays, studies with patients and artificial intelligence approaches.